Elpen

ELPEN is a privately family-owned, middle sized Greek pharmaceutical company with operations worldwide. Established in 1965, the group currently has more than 1100 employees and an annual turnover of €250 million. With state of the art production and research facilities, ELPEN specializes in the development, production and commercialization of branded generic products and value added medicines to more than 40 countries worldwide. All of them are manufactured under the strict EU guidelines.

ELPEN has a production facility of 10.000m2 and its research facility (The Experimental, Educational and Research Center ELPEN) is the first and largest laboratory for experimental biomedical research and training center in Greece that originates from the private sector and it is ranked within the top 5 in Europe. If you are interested in learning more about the rich pipeline of products that ELPEN is working on, please contact our International Business Development team.